Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil in head and neck squamous cell carcinoma in vitro

Ryuji Yasumatsu, Torahiko Nakashima, Shizuo Komune

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

5-Fluorouracil (5-FU) is a widely used drug in head and neck squamous cell carcinoma (HNSCC). In the anabolic pathway of 5-FU, the first step in activation of the drug is phosphorylation of 5-FU by orotate phosphoribosyltransferase (OPRT), which directly metabolizes 5-FU to 5-fluorouridine monophosphate (FUMP) in the presence of 5-phosphoribosyl-1-pyrophosphate. To date, OPRT expression in the tumors has been related to the clinical response or survival of cancer patients receiving 5-FU-based chemotherapy. In this study, we examined whether OPRT expression correlates with the chemosensitivity to 5-FU and cell proliferation in HNSCC. We constitutively expressed an OPRT cDNA in an HNSCC cell line. The effects of OPRT expression on in vitro cell growth and 5-FU cytotoxicity were examined. OPRT transfection increases the cytotoxicity of 5-FU without affecting cell proliferation of HNSCC cells in vitro. These results indicate that OPRT expression plays an important role in the sensitivity of HNSCC to 5-FU chemotherapy.

Original languageEnglish
Article number649605
JournalJournal of Oncology
DOIs
Publication statusPublished - Apr 19 2012

Fingerprint

Orotate Phosphoribosyltransferase
Transferases
Fluorouracil
Genes
Phosphoribosyl Pyrophosphate
Cell Proliferation
Carcinoma, squamous cell of head and neck
In Vitro Techniques
Drug Therapy
Transfection
Neoplasms
Complementary DNA
Phosphorylation
Cell Line
Survival

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

@article{88242d97dfb4432f8b8fe75c9b9e0abd,
title = "Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil in head and neck squamous cell carcinoma in vitro",
abstract = "5-Fluorouracil (5-FU) is a widely used drug in head and neck squamous cell carcinoma (HNSCC). In the anabolic pathway of 5-FU, the first step in activation of the drug is phosphorylation of 5-FU by orotate phosphoribosyltransferase (OPRT), which directly metabolizes 5-FU to 5-fluorouridine monophosphate (FUMP) in the presence of 5-phosphoribosyl-1-pyrophosphate. To date, OPRT expression in the tumors has been related to the clinical response or survival of cancer patients receiving 5-FU-based chemotherapy. In this study, we examined whether OPRT expression correlates with the chemosensitivity to 5-FU and cell proliferation in HNSCC. We constitutively expressed an OPRT cDNA in an HNSCC cell line. The effects of OPRT expression on in vitro cell growth and 5-FU cytotoxicity were examined. OPRT transfection increases the cytotoxicity of 5-FU without affecting cell proliferation of HNSCC cells in vitro. These results indicate that OPRT expression plays an important role in the sensitivity of HNSCC to 5-FU chemotherapy.",
author = "Ryuji Yasumatsu and Torahiko Nakashima and Shizuo Komune",
year = "2012",
month = "4",
day = "19",
doi = "10.1155/2012/649605",
language = "English",
journal = "Journal of Oncology",
issn = "1687-8450",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil in head and neck squamous cell carcinoma in vitro

AU - Yasumatsu, Ryuji

AU - Nakashima, Torahiko

AU - Komune, Shizuo

PY - 2012/4/19

Y1 - 2012/4/19

N2 - 5-Fluorouracil (5-FU) is a widely used drug in head and neck squamous cell carcinoma (HNSCC). In the anabolic pathway of 5-FU, the first step in activation of the drug is phosphorylation of 5-FU by orotate phosphoribosyltransferase (OPRT), which directly metabolizes 5-FU to 5-fluorouridine monophosphate (FUMP) in the presence of 5-phosphoribosyl-1-pyrophosphate. To date, OPRT expression in the tumors has been related to the clinical response or survival of cancer patients receiving 5-FU-based chemotherapy. In this study, we examined whether OPRT expression correlates with the chemosensitivity to 5-FU and cell proliferation in HNSCC. We constitutively expressed an OPRT cDNA in an HNSCC cell line. The effects of OPRT expression on in vitro cell growth and 5-FU cytotoxicity were examined. OPRT transfection increases the cytotoxicity of 5-FU without affecting cell proliferation of HNSCC cells in vitro. These results indicate that OPRT expression plays an important role in the sensitivity of HNSCC to 5-FU chemotherapy.

AB - 5-Fluorouracil (5-FU) is a widely used drug in head and neck squamous cell carcinoma (HNSCC). In the anabolic pathway of 5-FU, the first step in activation of the drug is phosphorylation of 5-FU by orotate phosphoribosyltransferase (OPRT), which directly metabolizes 5-FU to 5-fluorouridine monophosphate (FUMP) in the presence of 5-phosphoribosyl-1-pyrophosphate. To date, OPRT expression in the tumors has been related to the clinical response or survival of cancer patients receiving 5-FU-based chemotherapy. In this study, we examined whether OPRT expression correlates with the chemosensitivity to 5-FU and cell proliferation in HNSCC. We constitutively expressed an OPRT cDNA in an HNSCC cell line. The effects of OPRT expression on in vitro cell growth and 5-FU cytotoxicity were examined. OPRT transfection increases the cytotoxicity of 5-FU without affecting cell proliferation of HNSCC cells in vitro. These results indicate that OPRT expression plays an important role in the sensitivity of HNSCC to 5-FU chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84859786386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859786386&partnerID=8YFLogxK

U2 - 10.1155/2012/649605

DO - 10.1155/2012/649605

M3 - Article

JO - Journal of Oncology

JF - Journal of Oncology

SN - 1687-8450

M1 - 649605

ER -